Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Incidence of influenza-like illness into a cohort of patients affected by chronic inflammatory rheumatism and treated with biological agents

S.L. Bello, L. Serafino, C. Bonali, N. Terlizzi, C. Fanizza, C. Anecchino, G. Lapaldula

299-306

11-12-2012

https://doi.org/10.4081/reumatismo.2012.299

2236

PDF: 1196
Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

M. Romano, I. Pontikaki, M. Gattinara, I. Ardoino, C. Donati, P. Boracchi, P.L. Meroni, V. Gerloni

278-285

17-03-2014

https://doi.org/10.4081/reumatismo.2013.682

2607

PDF: 1351
Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?

J. Mencarini, M. Spinicci, F. Bartalesi

144-147

16-12-2016

https://doi.org/10.4081/reumatismo.2016.897

1809

PDF: 1101
Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study

R. Talotta, A. Berzi, F. Atzeni, D. Dell'Acqua, P. Sarzi Puttini, D. Trabattoni

83-89

09-09-2016

https://doi.org/10.4081/reumatismo.2016.875

1825

PDF: 887

IL RUOLO DEI LINFOCITI TH9 NELL'ARTRITE REUMATOIDE E NELLA RISPOSTA AL TRATTAMENTO CON INFLIXIMAB.: 513
GISEA: an Italian biological agents registry in rheumatology

G. Lapadula, G. Ferraccioli, C. Ferri, L. Punzi, F. Trotta

155-164

09-11-2011

https://doi.org/10.4081/reumatismo.2011.155

2225

PDF: 1532
A short history of anti-rheumatic therapy - VII. Biological agents

G. Pasero, P. Marson, B. Gatto

185-194

09-11-2011

https://doi.org/10.4081/reumatismo.2011.185

1473

PDF: 1212
Are biological drugs safe in pregnancy?

A. Calligaro, A. Hoxha, A. Ruffatti, L. Punzi

304-317

31-03-2015

https://doi.org/10.4081/reumatismo.2014.798

3696

PDF: 2385
The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study

M. Manara, L. Arcarese, G. Bianchi, V. Corbelli, O. Epis, R. Laurenti, A. Migliore, M. Muratore, A. Roncaglione, M. Rossini, M. Savo, L. Sinigaglia

188-194

31-12-2016

https://doi.org/10.4081/reumatismo.2016.903

1723

PDF: 908
MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

132-139

https://doi.org/10.4081/reumatismo.2009.132

1892

PDF: 1120
The bisphosponates: chemical characteristics, skeletal biological effects and extra-skeletal effects

A. Corrado, F.P. Cantatore

142-153

11-04-2005

https://doi.org/10.4081/reumatismo.2005.142

874

PDF: 1881
Successful treatment of refractory adult onset Still’s disease with rituximab

N. Belfeki, M. Smiti Khanfir, F. Said, A. Hamzaoui, T. Ben Salem, I. Ben Ghorbel, M. Lamloum, M.H. Houman

159-162

16-12-2016

https://doi.org/10.4081/reumatismo.2016.888

2362

PDF: 1167
Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis

G. Andrisani, E. Gremese, L. Guidi, A. Papa, M. Marzo, C. Felice, D. Pugliese, A. Armuzzi

75-78

27-05-2013

https://doi.org/10.4081/reumatismo.2013.75

2937

PDF: 877
Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

Irene Pontikaki, Valeria Gerloni, Maurizio Gattinara, Alfredomaria Lurati, Alessandra Salmaso, Gabriele De Marco, Barbara Teruzzi, Elisabetta Valcamonica, Flavio Fantini

31-38

https://doi.org/10.4081/reumatismo.2006.31

1772

PDF: 2506
Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab

M. Gutierrez, A. Becciolini, C. Bertolazzi, L. Di Geso, M. Tardella, A. Ariani, E. Filippucci, W. Grassi

221-224

https://doi.org/10.4081/reumatismo.2010.221

1162

PDF: 678
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

173-177

19-11-2020

https://doi.org/10.4081/reumatismo.2020.1289

1586

PDF: 986
Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, Francesco Cipollone, Fabio Lobefaro, Paolo Amerio

27-01-2025

https://doi.org/10.4081/reumatismo.2025.1694

1312

PDF: 355
Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vγ9/Vδ2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?

A.R. Giardina, A. Accardo-Palumbo, F. Ciccia, A. Ferrante, A. Principato, R. Impastato, G. Triolo

21-26

https://doi.org/10.4081/reumatismo.2009.21

1400

PDF: 1078
CONVENTIONAL THERAPY OF PSORIATIC ARTHRITIS: EVIDENCE-BASED REVIEW

N.J. Mchugh, E.R. Soriano

81-84

https://doi.org/10.4081/reumatismo.2007.1s.81

752

PDF: 745
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

P. Sarzi- Puttini, M. Antivalle, A. Marchesoni, E.G. Favalli, R. Gorla, M. Filippini, R. Caporali, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

290-295

https://doi.org/10.4081/reumatismo.2008.290

2040

PDF: 1051
Top 100 cited articles on ankylosing spondylitis

F. Bagcier, O.V. Yurdakul, E. Ozduran

218-227

18-01-2021

https://doi.org/10.4081/reumatismo.2020.1325

1850

PDF: 989
Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco

224-235

https://doi.org/10.4081/reumatismo.2003.224

1096

PDF: 2490
Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

41-49

https://doi.org/10.4081/reumatismo.2008.41

1149

PDF: 765
Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

S. Zingarelli, P. Airò, M. Frassi, C. Bazzani, M. Scarsi, M. Puoti

22-27

https://doi.org/10.4081/reumatismo.2008.22

1148

PDF: 937

1 - 23 of 23 items

Search

Search Results

Incidence of influenza-like illness into a cohort of patients affected by chronic inflammatory rheumatism and treated with biological agents

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients

Risk of cytomegalovirus reactivation in patients with immune-mediated inflammatory diseases undergoing biologic treatment: a real matter?

Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study

GISEA: an Italian biological agents registry in rheumatology

A short history of anti-rheumatic therapy - VII. Biological agents

Are biological drugs safe in pregnancy?

The impact on disability of initial treatment with methotrexate in patients with rheumatoid arthritis: results from the MARI study

MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

The bisphosponates: chemical characteristics, skeletal biological effects and extra-skeletal effects

Successful treatment of refractory adult onset Still’s disease with rituximab

Achievement of sustained deep remission with adalimumab in a patient with both refractory ulcerative colitis and seronegative erosive rheumatoid arthritis

Side effects of anti-TNFa therapy in juvenile idiopathic arthritis

Polyarthritis flare in patient with ankylosing spondylitis treated with infliximab

COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vγ9/Vδ2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis?

CONVENTIONAL THERAPY OF PSORIATIC ARTHRITIS: EVIDENCE-BASED REVIEW

Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

Top 100 cited articles on ankylosing spondylitis

Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

authors

reviewers

Categories

indexing

Keywords